P2.11-12 Metabolomic Analysis in Lung Cancer for Screening and Early Detection

Journal of Thoracic Oncology- United States

doi 10.1016/j.jtho.2018.08.1359

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P2.11-19 MicroRNAs as Liquid Biopsy Biomarkers for Early Detection in Lung Cancer.

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-13 Precise Early Detection of Lung Cancer and Blood Cell Circuit

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-14 Malignancy Associated Change and the LuCED® Test for Detection of Early Stage Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-23 Risk Perception Among a Lung Cancer Screening Population

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-04 Treatment Capacity Required for Implementing Lung Cancer Screening in the United States

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-18 a Comprehensive Lung Cancer Screening Program: 5 Years in Review

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-03 Cardiovascular Risk Prediction in a Community-Based Lung Cancer Screening Programme

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-05 Recruitment Strategies for the Lung Cancer Screening Pilot for People at High Risk

Journal of Thoracic Oncology

Respiratory Medicine

English

Investigation of Metabolomic Blood Biomarkers for Detection of Adenocarcinoma Lung Cancer

Cancer Epidemiology Biomarkers and Prevention

English